化工社化工社 化学情報印刷レポート · 研究参考用
HCID 175487作成日:2026年11月1日
Chromate(3-), bis(3-((4,5-dihydro-3-methyl-5-(oxo-kappaO)-1-phenyl-1H-pyrazol-4-yl)azo-kappaN1)-4-(hydroxy-kappaO)-5-nitrobenzenesulfonato(3-))-, sodium dihydrogen
Chromate(3-),bis[3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-4-hydroxy-5-nitrobenzenesulfonato(3-)]-,sodium dihydrogen · Chromate(3-), bis[3-[(4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo]-4-hydroxy-5-nitrobenzenesulfonato(3-)]-, sodium dihydrogen · Chromate(3-), bis3-4,5-dihydro-3-methyl-5-(oxo-.kappa.O)-1-phenyl-1H-pyrazol-4-ylazo-.kappa.N1-4-(hydroxy-.kappa.O)-5-nitrobenzenesulfonato(3-)-, sodium dihydrogen
https://huagongshe.com/ja/chemical/175487

識別子と物理属性
| CAS No. | 73507-64-9 |
|---|
| 分子式 | C32H22CrN10NaO14S2 |
|---|
| 平均分子量 | 909.7 g/mol |
|---|
| 単同位体質量 | 909.006112 g/mol |
|---|
| SMILES | CC1=NN(c2ccccc2)C(=O)C1=NN=C1C=C(S(=O)(=O)[O-])C=C(N([O-])[O-])C1=O.Cc1nn(-c2ccccc2)c([O-])c1N=Nc1cc(S(=O)(=O)[O-])cc([N+](=O)[O-])c1[O-].[Cr+3].[H+].[H+].[Na+] |
|---|
| InChIKey | NCQIJCAMPYGCRD-GLCFPVLVSA-L |
|---|
| PubChem CID | 175487 |
|---|
| EC No. | 686-728-5 |
|---|
| DTXSID | DTXSID70904925 |
|---|
化学・物理的性質
| 極性表面積 | 389 |
|---|
| 水素結合供与体数 | 2 |
|---|
| 水素結合受容体数 | 21 |
|---|
| 回転可能結合数 | 5 |
|---|
| 重原子数 | 60 |
|---|
| 形式電荷 | 0 |
|---|
| 複雑度 | 705 |
|---|
| EPAの化学物質情報 | Chromate(3-), bis[3-[[4,5-dihydro-3-methyl-5-(oxo-.kappa.O)-1-phenyl-1H-pyrazol-4-yl]azo-.kappa.N1]-4-(hydroxy-.kappa.O)-5-nitrobenzenesulfonato(3-)]-, sodium dihydrogen (73507-64-9) |
|---|
安全性と法規制
| GHS 分類 | This chemical does not meet GHS hazard criteria for 83.3% (5 of 6) of all reports.WarningH319 (16.7%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]P264+P265, P273, P280, P305+P351+P338, P337+P317, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 6 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies. |
|---|
| Hazard Classes and Categories | Eye Irrit. 2 (16.7%) |
|---|
| TSCA 収載状態 | TSCA listed |
|---|